News from us and our partners

Tags

Topics

0 results

Feature
17 October, 2022
The origins of our Industrial Biotech strategy
News
14 October, 2022
Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners
News
13 October, 2022
Inotrem announces positive outcome of its Phase II ASTONISH trial in septic shock patients demonstrating efficacy of nangibotide
News
13 October, 2022
DNA Script appoints Madoo Varma as VP business development
News
11 October, 2022
Muna Therapeutics awarded $4.9M grant from The Michael J. Fox Foundation for Parkinson's research
News
30 September, 2022
Biosyntia raises €17.5 million in Series B follow-on to advance sustainable production of active ingredients
News
29 September, 2022
AFYREN inaugurates its first factory, AFYREN NEOXY, a first-of-its-kind biorefinery
News
26 September, 2022
TISSIUM appoints Sara Toyloy as independent Board member
News
21 September, 2022
NodThera announces positive Phase 1 study readouts for the NLRP3 inflammasome inhibitors NT-0796 and NT-0249
News
21 September, 2022
Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China
News
13 September, 2022
Antoine Papiernik and Sylvain Gariel urge France to invest in vaccines
News
9 September, 2022
May Health solidifies veteran executive team with appointment of women’s health care leader Anne Morrissey as CEO
News
8 September, 2022
AAVantgarde Bio appoints Dr. Natalia Misciattelli as Chief Executive Officer
News
6 September, 2022
Synthace appoints Dr. Donald Deieso as new Board Chair
News
6 September, 2022
Noema Pharma announces completion of enrollment in the Trigeminal Neuralgia Electronic Diary (TNED) validation study
News
2 September, 2022
Abivax announces successful oversubscribed €49.2 million crossover financing with top-tier U.S. and European biotech investors

The origins of our Industrial Biotech strategy

Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners

Inotrem announces positive outcome of its Phase II ASTONISH trial in septic shock patients demonstrating efficacy of nangibotide

DNA Script appoints Madoo Varma as VP business development

Muna Therapeutics awarded $4.9M grant from The Michael J. Fox Foundation for Parkinson's research

Biosyntia raises €17.5 million in Series B follow-on to advance sustainable production of active ingredients

AFYREN inaugurates its first factory, AFYREN NEOXY, a first-of-its-kind biorefinery

TISSIUM appoints Sara Toyloy as independent Board member

NodThera announces positive Phase 1 study readouts for the NLRP3 inflammasome inhibitors NT-0796 and NT-0249

Inventiva and Sino Biopharm announce licensing and collaboration agreement to develop and commercialize lanifibranor in Greater China

Antoine Papiernik and Sylvain Gariel urge France to invest in vaccines

May Health solidifies veteran executive team with appointment of women’s health care leader Anne Morrissey as CEO

AAVantgarde Bio appoints Dr. Natalia Misciattelli as Chief Executive Officer

Synthace appoints Dr. Donald Deieso as new Board Chair

Noema Pharma announces completion of enrollment in the Trigeminal Neuralgia Electronic Diary (TNED) validation study

Abivax announces successful oversubscribed €49.2 million crossover financing with top-tier U.S. and European biotech investors